TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 186 filers reported holding TANDEM DIABETES CARE INC in Q3 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,114,204 | +25.0% | 14,046 | -0.9% | 0.03% | +16.0% |
| Q3 2021 | $1,691,973 | +329.2% | 14,173 | +250.2% | 0.02% | +316.7% |
| Q2 2021 | $394,178 | +10.2% | 4,047 | -0.1% | 0.01% | +20.0% |
| Q1 2021 | $357,589 | -11.5% | 4,052 | -4.0% | 0.01% | -16.7% |
| Q4 2020 | $404,057 | -15.6% | 4,223 | +0.1% | 0.01% | -25.0% |
| Q3 2020 | $478,857 | +13.4% | 4,219 | -1.2% | 0.01% | +14.3% |
| Q2 2020 | $422,289 | -61.3% | 4,269 | -74.8% | 0.01% | -69.6% |
| Q1 2020 | $1,091,376 | +3.4% | 16,960 | -4.2% | 0.02% | +27.8% |
| Q4 2019 | $1,055,097 | -0.4% | 17,700 | -1.5% | 0.02% | 0.0% |
| Q3 2019 | $1,059,694 | -2.0% | 17,967 | +7.2% | 0.02% | 0.0% |
| Q2 2019 | $1,081,548 | +3.5% | 16,763 | +1.9% | 0.02% | -5.3% |
| Q1 2019 | $1,044,893 | +62.9% | 16,455 | -2.6% | 0.02% | +46.2% |
| Q4 2018 | $641,275 | -9.0% | 16,889 | +2.7% | 0.01% | 0.0% |
| Q3 2018 | $704,589 | – | 16,447 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,022,257 | $60,293,000 | 5.97% |
| APIS CAPITAL ADVISORS, LLC | 50,000 | $2,949,000 | 4.62% |
| SECTORAL ASSET MANAGEMENT INC | 432,815 | $25,527,000 | 4.40% |
| CROWN ADVISORS MANAGEMENT, INC. | 75,000 | $4,424,000 | 2.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 199,410 | $11,761,000 | 2.66% |
| Asymmetry Capital Management, L.P. | 18,995 | $1,120,000 | 2.40% |
| Redmile Group, LLC | 1,160,401 | $68,440,000 | 2.29% |
| FRIESS ASSOCIATES LLC | 501,985 | $29,607,000 | 2.29% |
| Atika Capital Management LLC | 142,000 | $8,375,000 | 1.76% |
| Chicago Capital, LLC | 433,083 | $25,543,000 | 1.71% |